A guide for staff working in radiation oncology
Patients undergoing radiation therapy may also be receiving concurrent chemotherapy, targeted therapy or immunotherapy. These treatments can be broadly classified as systemic anti-cancer therapies (SACT).
It is important that all staff involved in the care of patients receiving SACT have an understanding of how these drugs may impact patient care.
In this rapid learning, you will learn:
- how SACT drugs work
- possible side effects of SACT
- considerations for radiation therapy e.g. timing of radiotherapy & safe handling recommendations.
Viewing this on mobile? Tell us what you thought. Complete the survey.
This job aid is designed to assist radiation oncology staff care for patients receiving concurrent SACT. It contains relevant information about common SACT protocols and how these may impact a patient’s radiotherapy. Download the job aid now.
To view more medical oncology protocols please visit eviQ.
- Bourke, J.M., O'Sullivan, M. and Khattak, M.A., 2016. Management of adverse events related to new cancer immunotherapy (immune checkpoint inhibitors). The Medical Journal of Australia, 205(9), pp.418-424.
- Cancer Institute NSW. eviQ: cancer treatments online [online]. Available from URL: https://www.eviq.org.au/
- Cancer Institute NSW. eviQ Education, Antineoplastic Drug Administration course [online]. Available from: https://education.eviq.org.au/courses/antineoplastic-drug-administration-course
- Pardoll, D.M., 2012. The blockade of immune checkpoints in cancer immunotherapy. Nature Reviews Cancer, 12(4), p.252.
- Weiner, G.J., 2007. Monoclonal antibody mechanisms of action in cancer. Immunologic research, 39(1-3), pp.271-27